|
Hodgman has held senior leadership positions at a number of biotechnology and technology companies. In 2005, he was President and Chief Executive Officer of Aerogen, Inc. where he directed the company’s merger with Nektar Corporation. From 1998 to 2005, he served as Chairman, President and CEO of Cygnus, Inc., where he led the commercialization of the first U.S. Food and Drug Administration-approved non-invasive continuous glucose monitoring system for patients with diabetes. Hodgman also served as Vice President of Finance, Chief Financial Officer of Cygnus from 1994 to 1998 in addition to serving as President of Cygnus’ Diagnostic Division. He previously served as Vice President of Operations and Finance, Chief Financial Officer of Central Point Software, Inc.; Vice President of Finance and Administration, Chief Financial Officer of Ateq Corporation; and as a management consultant for Price Waterhouse. He currently serves on the boards of a number of publicly and privately held biotechnology and technology companies. Hodgman holds a B.S. from Brigham Young University and an M.B.A. from the University of Utah. | 